Literature DB >> 17609300

Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure.

Jens Juel Christiansen1, Christian B Djurhuus, Claus H Gravholt, Per Iversen, Jens Sandahl Christiansen, Ole Schmitz, Jørgen Weeke, Jens Otto Lunde Jørgensen, Niels Møller.   

Abstract

CONTEXT: Cortisol is an important catabolic hormone, but little is known about the metabolic effects of acute cortisol deficiency.
OBJECTIVE: The objective of the study was to test whether clinical symptoms of weight loss, fatigue, and hypoglycemia could be explained by altered energy expenditure, protein metabolism, and insulin sensitivity during cortisol withdrawal in adrenocortical failure. DESIGN, PARTICIPANTS, AND INTERVENTION: We studied seven women after 24-h cortisol withdrawal and during replacement control during a 3-h basal period and a 3-h glucose clamp.
RESULTS: Cortisol withdrawal generated cortisol levels close to zero, a 10% decrease in basal energy expenditure, increased TSH and T(3) levels, and increased glucose oxidation. Whole-body glucose and phenylalanine turnover were unaltered, but forearm phenylalanine turnover was increased. During the clamp glucose, infusion rates rose by 70%, glucose oxidation rates increased, and endogenous glucose production decreased. Urinary urea excretion decreased by 40% over the 6-h study period.
CONCLUSIONS: Cortisol withdrawal increased insulin sensitivity in terms of increased glucose oxidation and decreased endogenous glucose production; this may induce hypoglycemia in adrenocortical failure. Energy expenditure and urea loss decreased, indicating that weight and muscle loss in Addison's disease is caused by other mechanisms, such as decreased appetite. Increased muscle protein breakdown may amplify the loss of muscle protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609300     DOI: 10.1210/jc.2007-0445

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

1.  Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis.

Authors:  Thomas S Voss; Mikkel H Vendelbo; Ulla Kampmann; Steen B Pedersen; Thomas S Nielsen; Mogens Johannsen; Mads V Svart; Niels Jessen; Niels Møller
Journal:  Diabetologia       Date:  2018-12-01       Impact factor: 10.122

Review 2.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

3.  Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome P450 inhibition: a patent evaluation WO2015048311 (A1).

Authors:  Richard L Schroeder; Phan Tram; Jiawang Liu; Maryam Foroozesh; Jayalakshmi Sridhar
Journal:  Expert Opin Ther Pat       Date:  2015-10-29       Impact factor: 6.674

4.  Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.

Authors:  Lara Aygen Øzbay; Niels Møller; Claus Juhl; Mette Bjerre; Jan Carstens; Jørgen Rungby; Kaj Anker Jørgensen
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

5.  Systems characterization of differential plasma metabolome perturbations following thrombotic and non-thrombotic myocardial infarction.

Authors:  Patrick J Trainor; Bradford G Hill; Samantha M Carlisle; Eric C Rouchka; Shesh N Rai; Aruni Bhatnagar; Andrew P DeFilippis
Journal:  J Proteomics       Date:  2017-03-22       Impact factor: 4.044

6.  Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in Rats.

Authors:  Linjing Zhao; Aihua Zhao; Tianlu Chen; Wenlian Chen; Jiajian Liu; Runmin Wei; Jing Su; Xuelan Tang; Keyi Liu; Ran Zhang; Guoxiang Xie; Jun Panee; Mingfeng Qiu; Wei Jia
Journal:  J Proteome Res       Date:  2016-06-20       Impact factor: 4.466

7.  Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's Disease).

Authors:  Gesine Meyer; Annika Hackemann; Juergen Reusch; Klaus Badenhoop
Journal:  Diabetes Technol Ther       Date:  2012-01-13       Impact factor: 6.118

8.  Ramadan fasting in patients with adrenal insufficiency.

Authors:  Mélika Chihaoui; Fatma Chaker; Meriem Yazidi; Wafa Grira; Zohra Ben Amor; Ons Rejeb; Hedia Slimane
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

Review 9.  The role of the circadian clock system in physiology.

Authors:  Violetta Pilorz; Charlotte Helfrich-Förster; Henrik Oster
Journal:  Pflugers Arch       Date:  2018-01-04       Impact factor: 3.657

10.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.